Interview: Data Driven and Fungi Focused – The Future of Microbiome Science - Sam Schatz
Sam Schatz is the CEO of Biohm Technologies, a company pioneering microbiome-based ingredients using proprietary datasets that integrate genetic analysis, metadata, and AI. Joining Biohm in 2021 as President, he became CEO in 2023, driving business expansion, capital raising, and P&L management. Previously, Sam was Managing Director at AeroFarms, scaling it to 300+ employees. With more than 15 years of experience in management and entrepreneurship, Sam holds an MSc from London School of Economics and a BA from Columbia University and serves on leadership councils at 92NY and YPO Polaris.
-----
In this episode of Leading for Wellness, Liesl Bernard interviews Sam Schatz, CEO of Biohm Technologies, about the intersection of data science and biology in understanding the human microbiome. Sam discusses the importance of both bacterial and fungal microbiome data, the balance of Candida in gut health, and the innovative testing methods used to personalize health recommendations.
The conversation also explores the link between microbiome health and longevity, as well as Biohm's AI-driven discovery platform for developing new health products.
Sam also discusses the innovative approaches of Biohm Technologies in enhancing nutrient absorption through their product Mycosa, the importance of expanding microbiome research beyond gut health, and the future of microbiome science with a focus on postbiotics.
He emphasizes the need for targeted formulations based on clinical data and the role of fungi in gut health.
Additionally, he shares insights on cultivating a culture of innovation within his remote team and personal health strategies that contribute to longevity and wellbeing.
Listen to Snippet :